SS
Saurabh Shrikant Mukewar
About Saurabh Shrikant Mukewar
Data last updated:
Saurabh Shrikant Mukewar has 6 years in corporate governance. Holds Director role. Currently with 1 company, including Midas Multispeciality Hospital Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Midas Multispeciality Hospital Private Limited at ₹85.65 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Jan 2020 | 2010 | ₹85.65 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Saurabh Shrikant Mukewar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saurabh Shrikant Mukewar
Saurabh Shrikant Mukewar has 6 years in corporate governance. Holds Director role. Currently with 1 company, including Midas Multispeciality Hospital Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Midas Multispeciality Hospital Private Limited at ₹85.65 Cr (FY 2025).
Saurabh Shrikant Mukewar is associated with 1 company as Director, including Midas Multispeciality Hospital Private Limited (₹85.65 Cr).
Saurabh Shrikant Mukewar has expertise in General Business.
Saurabh Shrikant Mukewar has 6 years in corporate governance.
By reported revenue, the largest current company of Saurabh Shrikant Mukewar is Midas Multispeciality Hospital Private Limited, with revenue of ₹85.65 Cr (FY 2025).
Saurabh Shrikant Mukewar currently holds positions at 1 company: Midas Multispeciality Hospital Private Limited (₹85.65 Cr).